Kuros Biosciences is a biotechnology company based in Switzerland that develops products for bone repair and regeneration. Its main offering is a family of synthetic bone graft substitutes used in spinal fusion and orthopedic surgery, and it also develops biologic products that combine a bone growth factor with a carrier matrix to aid bone healing. Its customers are surgeons, hospitals and medical device partners in markets for orthobiologics and spine care.
The shares are listed on the London Exchange in UK under the code 0RHR, and the price on this page is in pounds sterling (GBP). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #3119 of 3787 on the London Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendWeak
24/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-7.5%
From 52-week high-36.3%
MomentumWeak
30/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-1.0%
6-month return-10.6%
12-month, skipping last month-42.3%
Stability (higher is calmer)Weak
25/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)50.3%
Worst drawdown, 1 year (smaller is calmer)-47.2%
LiquidityWeak
43/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.39M GBP
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 16.46 – 32.48Daily closes, split-adjusted
Signals
50-day average18.94
200-day average21.85
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.98
Technical summary
Daily
Bullish
10 bullish · 1 neutral · 5 bearish
Weekly
Neutral
4 bullish · 1 neutral · 5 bearish
Monthly
Bearish
2 bullish · 1 neutral · 5 bearish
Moving averages (daily)
SMA 10
18.57
Bullish
EMA 10
18.92
Bullish
SMA 20
18.42
Bullish
EMA 20
18.61
Bullish
SMA 50
18.94
Bullish
EMA 50
18.97
Bullish
SMA 100
19.80
Bullish
EMA 100
19.88
Bullish
SMA 200
21.85
Bearish
EMA 200
21.34
Bearish
Oscillators (daily)
RSI (14)
60.64
Neutral
MACD (12, 26)
0.20
Bullish
Momentum (12)
11.96
Bullish
Stochastic %K (14)
90.71
Bearish
Williams %R (14)
-9.29
Bearish
CCI (20)
196.2
Bearish
Pivot points (classic, last session)
S3
18.75
S2
19.19
S1
19.71
Pivot
20.15
R1
20.67
R2
21.11
R3
21.63
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in GBP. Educational only, not financial advice.
